Androgen Receptor Antibodies

Santa Cruz Biotechnology features a diverse variety of Androgen Receptor Antibodies for studying androgen receptor signaling pathways. Androgen Receptor Antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The androgen receptor is a critical nuclear receptor that mediates the effects of androgens, such as testosterone, influencing numerous physiological processes including development, metabolism, and reproductive functions. Dysregulation of androgen receptor signaling is implicated in various diseases, including prostate cancer and androgen insensitivity syndrome, making androgen receptor research essential for understanding these conditions. Researchers frequently utilize androgen receptor monoclonal antibodies to investigate hormone-dependent gene regulation and cellular responses. Advanced imaging techniques combined with specific molecular markers enable detailed analysis of androgen receptor localization and activation states. Understanding androgen receptor mechanisms has led to significant developments in therapeutic approaches for hormone-related disorders. Santa Cruz Biotechnology monoclonal antibodies for androgen receptor research support scientists worldwide in advancing our understanding of hormone signaling and disease mechanisms.